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Because women experience a bewildering array of chemicals, foods and lifestyles, only 
profound effects on preventing or promoting breast cancer are detectible in human 
studies. Subtle or delayed effects can be detected in animal models. Mammary tumors 
in ACI rats share important similarities with the majority of human breast cancers. The 
link between life time estrogen exposure and breast cancer risk in humans is well 
established. A high percentage of human breast cancers express ER, are stimulated to 
grow by the addition of exogenous estrogen, and respond to the antiestrogen tamoxifen. 
The ACI rat is the only rodent model in which estrogen-sensitive tumors are induced by 
estrogen. The ACI.COP-Ept2 substrain, derived from the ACI rat, develops mammary 
tumors similar to those of the ACI rat, but with reduced pituitary hyperplasia. We show 
that estrogen-induced mammary tumors in ACI.COP-Ept2 express ERα and respond to 
tamoxifen. Furthermore, tumors express ERβ, progesterone receptor and Her2/neu. 
The average latency was 183±6 days (n=24) and average tumor burden 1,107±415 
mm3. The similarities of ACI.COP-Ept2 tumors to human breast cancers make this a 
valuable model for determining which of the myriad of lifestyle and diet choices 
reportedly protecting women from breast cancer actually reduce cancer incidence. 
